Sign In

Communications of the ACM

ACM News

Chinese Scientists to Pioneer First Human Crispr Trial

Cancer cell and T lymphocytes

Genes in immune cells will be edited in an effort to turbocharge their attack on tumors.

Credit: Steve Gschmeissner/Science Photo Library

Chinese scientists are on the verge of being first in the world to inject people with cells modified using the CRISPR–Cas9 gene-editing technique.

From Nature
View Full Article



No entries found